Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02213523 · ClinicalTrials.gov registry record · NA
ABG Oxidative Stress Study Protocol-1
A NA study, sponsored by Access Business Group.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02213523: Completed NA study, sponsored by Access Business Group.
NCT02213523 is a NA study that has completed, run by Access Business Group. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02213523, a NA study, has completed, sponsored by Access Business Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a proof of concept study that evaluates the response to oxidative stress in healthy men after taking plant concentrates.
Primary Outcome
Change in antioxidant biomarker from baseline to day 15
Interventions
- DIETARY_SUPPLEMENT Plant concentrate A
- DIETARY_SUPPLEMENT Plant concentrate B
- DIETARY_SUPPLEMENT Plant concentrate C
- DIETARY_SUPPLEMENT Plant concentrate D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT02213523 record still lists
NCT02213523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Plant concentrate A is the first listed.
NCT02213523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02213523 about?
NCT02213523 is a clinical study titled "ABG Oxidative Stress Study Protocol-1". This is a proof of concept study that evaluates the response to oxidative stress in healthy men after taking plant concentrates.
What is the current status of trial NCT02213523?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02213523?
The interventions under investigation include: Plant concentrate A (DIETARY_SUPPLEMENT), Plant concentrate B (DIETARY_SUPPLEMENT), Plant concentrate C (DIETARY_SUPPLEMENT), Plant concentrate D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02213523?
This trial is sponsored by Access Business Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02213523's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia